Carlsmed (CARL) Total Liabilities (2024 - 2026)

Carlsmed (CARL) has reported Total Liabilities for 3 consecutive years, with $34.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 22.97% year-over-year to $34.0 million; the trailing twelve-month figure through Jun 2026 stood at $34.0 million (up 22.97% YoY), and the FY2025 full-year result was $31.3 million, up 19.15% from the prior year.
• Total Liabilities grew to $34.0 million in Q2 2026 per CARL's latest filing, from $26.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $76.6 million in Q1 2025 and bottomed at $26.2 million in Q4 2024.
• Historically, Total Liabilities has averaged $41.6 million across 3 years, with a median of $31.3 million in 2025.
• The widest YoY moves for Total Liabilities: up 22.97% in 2026, down 65.38% in 2026.
• Over 3 years, Total Liabilities stood at $26.2 million in 2024, then increased by 19.15% to $31.3 million in 2025, then grew by 8.66% to $34.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $34.0 million, $26.5 million, and $31.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.